<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03481790</url>
  </required_header>
  <id_info>
    <org_study_id>AinShams Maternity Hospital</org_study_id>
    <nct_id>NCT03481790</nct_id>
  </id_info>
  <brief_title>Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy</brief_title>
  <official_title>The Effect of Orally Administered Iron-saturated Lactoferrin on Systemic Iron Homeostasis in Pregnant Women Suffering From Iron Deficiency and Iron Deficiency Anaemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy and tolerability of lactoferrin in contrast to ferrous
      sulphate in the context of iron deficiency anemia with pregnancy.

      Half of participants will receive lactoferrin, while the other half will receive ferrous
      sulphate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lactoferrin and Ferrous sulfate are used to treat iron deficiency anemia in pregnancy.

      Ferrous sulphate is the most commonly used treatment for iron deficiency anemia.

      Lactoferrin is a new generation oral iron that has long been recognized as a member of the
      transferrin family of proteins and an important regulator of the levels of free iron in the
      body fluids and has the ability to enhance iron binding. Preliminary evidence suggests that
      lactoferrin may represent a promising new strategy for oral iron replacement.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">March 5, 2018</completion_date>
  <primary_completion_date type="Actual">March 5, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin (Hb) level.</measure>
    <time_frame>4 weeks</time_frame>
    <description>to be measured before and after treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum ferritin level.</measure>
    <time_frame>4 weeks</time_frame>
    <description>to be measured before and after treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Iron Deficiency Anemia of Pregnancy</condition>
  <arm_group>
    <arm_group_label>Lactoferrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100mg of bovine lactoferrin (Pravotin sachets, Hygint, Egypt) twice a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ferrous sulphate + folic acid (vitamin B9)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>150mg of dried ferrous sulphate + folic acid (vitamin B9) 0.50mg (Ferrofol, E.I.P.I.C.O, Egypt) three capsules per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactoferrin</intervention_name>
    <description>(Pravotin sachets, Hygint, Egypt): 100 mg in 1/4 glass of water before meals twice a day for 4 weeks.</description>
    <arm_group_label>Lactoferrin</arm_group_label>
    <other_name>Pravotin</other_name>
    <other_name>MamyVital</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ferrous sulphate + folic acid (vitamin B9)</intervention_name>
    <description>(Ferrofol capsules, Eipico, Egypt): Dried ferrous sulphate 150 mg + Folic acid (Vitamin B9) 150 mg at least 1 hour before or 2 hours after meals three times a day for 4 weeks.</description>
    <arm_group_label>ferrous sulphate + folic acid (vitamin B9)</arm_group_label>
    <other_name>Ferrofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women with single fetus

          -  Hb count &lt; 11g/dL

          -  ferritin level &lt; 12 ng/dL

          -  Gestational age (14 - 30 weeks)

        Exclusion Criteria:

          -  Associated chronic medical disorder (CKD, liver disease, peptic ulcer and chronic
             blood loss).

          -  Associated bleeding disorder

          -  Anaemia requiring blood tranfusion (Hb &lt; 7g/dL)

          -  Hypersensitivity to iron preparations

          -  Haemoglobinopathies (G6PD, thalassemias, sickle cell disease)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Mamdouh</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams Maternity Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ain Shams Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Khaled Mohamed Balsha</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>iron deficiency anemia of pregnancy - lactoferrin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

